RTX Corporation (NYSE:RTX – Get Free Report) has been given an average rating of “Moderate Buy” by the twenty-seven analysts that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and eighteen have issued a buy recommendation on the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $226.75.
Several research firms have recently commented on RTX. Morgan Stanley reaffirmed an “overweight” rating and set a $240.00 price target (up from $220.00) on shares of RTX in a research report on Friday, July 24th. Deutsche Bank Aktiengesellschaft cut shares of RTX from a “buy” rating to a “hold” rating and set a $208.00 price objective on the stock. in a research note on Tuesday, October 13th. BNP Paribas Exane raised their price objective on shares of RTX from $220.00 to $265.00 and gave the stock an “outperform” rating in a report on Friday, July 24th. JPMorgan Chase & Co. boosted their target price on shares of RTX from $215.00 to $240.00 and gave the company an “overweight” rating in a research report on Friday, July 24th. Finally, DA Davidson boosted their target price on shares of RTX from $192.00 to $219.00 and gave the company a “neutral” rating in a research report on Monday, July 27th.
Read Our Latest Research Report on RTX
More RTX News
Here are the key news stories impacting RTX this week:
- Positive Sentiment: Q3 earnings beat expectations: RTX reported adjusted EPS of $2.26, up 33% from $1.70 a year earlier and well above the $1.78 analyst consensus. Revenue rose 11.1% to approximately $25 billion, also exceeding expectations. RTX Reports Q3 2026 Results
- Positive Sentiment: Guidance was raised again: Management increased its 2026 adjusted sales forecast to $97 billion-$97.5 billion, from $95 billion-$96 billion, while also raising its outlook for adjusted EPS and free cash flow. This was the third forecast increase of the year. RTX lifts 2026 forecasts
- Positive Sentiment: Record backlog supports longer-term visibility: More than $81 billion in quarterly commercial and defense awards pushed RTX’s backlog to a record $340 billion. Raytheon secured $59 billion in defense awards, while management said missile contracts provide nearly a decade of demand visibility. RTX: 3 Key Takeaways for Long-Term Investors
- Positive Sentiment: Defense contract momentum continued: RTX won $729 million in counter-drone contracts, including its first international KuRFS and Coyote sales. Separately, the Raytheon-Lockheed Martin Javelin joint venture received a $215 million U.S. Army launcher contract. RTX Secures $729M LIDS Contracts
- Neutral Sentiment: Cash-flow quality warrants monitoring: Operating cash flow improved substantially, but approximately $1.5 billion of the increase was attributed to selling receivables. Investors may therefore scrutinize how much of the improvement is recurring versus related to factoring. RTX cash recovery from selling receivables
- Negative Sentiment: Valuation and execution risks remain: Despite the favorable results, RTX trades at a relatively elevated earnings multiple, and investors remain focused on aerospace supply-chain constraints, program costs, and whether the large backlog converts into profitable cash flow.
RTX Stock Up 0.5%
RTX stock opened at $193.16 on Friday. The stock has a market cap of $260.34 billion, a PE ratio of 34.01, a price-to-earnings-growth ratio of 2.47 and a beta of 0.31. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.78 and a current ratio of 1.01. RTX has a one year low of $166.74 and a one year high of $226.88. The stock has a fifty day moving average of $198.46 and a 200 day moving average of $193.68.
RTX (NYSE:RTX – Get Free Report) last announced its earnings results on Tuesday, October 20th. The company reported $2.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.78 by $0.48. The business had revenue of $24.96 billion for the quarter, compared to analysts’ expectations of $24.11 billion. RTX had a return on equity of 13.99% and a net margin of 8.28%. The business’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same period last year, the firm posted $1.70 earnings per share. As a group, sell-side analysts predict that RTX will post 7.23 EPS for the current year.
Insiders Place Their Bets
In other news, insider Troy Brunk sold 8,557 shares of RTX stock in a transaction on Friday, July 24th. The shares were sold at an average price of $210.29, for a total transaction of $1,799,451.53. Following the transaction, the insider owned 8,809 shares in the company, valued at $1,852,444.61. This trade represents a 49.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Ramsaran Maharajh sold 13,655 shares of the business’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $223.92, for a total transaction of $3,057,627.60. Following the sale, the executive vice president directly owned 13,184 shares of the company’s stock, valued at approximately $2,952,161.28. The trade was a 50.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 29,222 shares of company stock worth $6,362,003. Company insiders own 0.10% of the company’s stock.
Hedge Funds Weigh In On RTX
A number of institutional investors have recently bought and sold shares of RTX. Benchmark Financial Wealth Advisors LLC lifted its holdings in shares of RTX by 15.5% in the 3rd quarter. Benchmark Financial Wealth Advisors LLC now owns 1,665 shares of the company’s stock worth $309,000 after acquiring an additional 223 shares during the last quarter. Parkside Investments LLC purchased a new position in shares of RTX during the 3rd quarter worth about $743,000. Physician Wealth Advisors Inc. grew its holdings in RTX by 8.3% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 1,136 shares of the company’s stock valued at $211,000 after purchasing an additional 87 shares during the last quarter. Pinnacle Associates Ltd. bought a new position in RTX during the 3rd quarter valued at about $41,876,000. Finally, Cohen Investment Advisors LLC grew its holdings in RTX by 0.3% during the 3rd quarter. Cohen Investment Advisors LLC now owns 30,067 shares of the company’s stock valued at $5,582,000 after purchasing an additional 83 shares during the last quarter. 86.50% of the stock is owned by institutional investors.
About RTX
RTX Corporation (NYSE: RTX) is an aerospace and defense company that develops and manufactures products and systems for commercial aviation, business aviation, military aircraft and government customers. Its portfolio includes aircraft engines, avionics, flight-control systems, cabin interiors, communications equipment, air and missile defense systems, precision weapons, radars and advanced sensors.
The company operates through three principal businesses: Collins Aerospace, which supplies aerospace systems and components; Pratt & Whitney, which designs and produces aircraft engines and related services; and Raytheon, which provides defense and intelligence technologies.
See Also
- Five stocks we like better than RTX
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Receive News & Ratings for RTX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTX and related companies with MarketBeat.com's FREE daily email newsletter.
